## 

## 

||Page|Page|
|---|---|---|
|Report of the Trustees and Strategic Report|I|— 12|
|Report of the Independent Auditors|13—16||
|Statement of Financial Actfvities||17|
|Balance Sheet||18|
|Cash Flow Statement||19|
|Notes to the Cash Flow Statement||20|
|Notes to the Financial Statements|21|—28|





## 

## 



## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

||Director|Integrated|Finance and|Capital|Workforce|
|---|---|---|---|---|---|
|Committees|Appointments|Governance|Audit|Development|and|
||||||Remuneration|
|Mr C Barratt|Chair|x|x||x|
|Mr C Brid9e||Chair|X|||
|Ms C Dodwell||||Chair||
|Mr R G Hammond|X|||X|Chair|
|DrCSlnce|X|x||||
|Mr L Marlow|||Chair|X|x|
|Ms S Watson||x||||
|Mr N Smillie||x||||
|Mr A Appleton||||X||



## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

|||2021|2020|
|---|---|---|---|
|||Unrestricted|Unrestricted|
|||funds|funds|
|||£|£|
||Notes|||
|INCOME||||
|DonatiQns and legacies||3,483|-|
|Investment income|4|-|-|
|Incoming resources from charitable activities||||
|Medical services provided|5|13,448,758|9,826,734|
|Other income||117,955|64,387|
|Total income||13,570,196|9,891,121|
|EXPENDITURE||||
|Charitable activities||||
|Medical services provided|6|14,224,294|10,797,843|
|Total expenditure||14,224,294|10,797,843|
|NET (EXPENDITURE)/INCOME||(654,098)|(906,722)|
|Total funds brought forward||12,090,140|12,996,862|
|TOTAL FUNDS CARRIED FORWARD||11,436,042|12,090,140|



## 



## 

|||2021||2020|
|---|---|---|---|---|
|||Unrestricted||Unrestricted|
|||funds||funds|
||Notes|£||£|
|FIXED ASSETS|||||
|Intangible assets<br>Tangible assets<br>Total Fixed Assets|13<br>14|15471<br>11,911,086<br>11,926,557||26,076<br>12,423,204<br>12,449280|
|CURRENT ASSETS<br>Stocks<br>Debtors; amounts falling due within one year<br>Cash at bank|15<br>16|280,419<br>1766,359<br>20|-|353,188<br>1236.656<br>522,172|
|||2.506.598||2,112,016|
|CREDITORS<br>Amounts falling due within one year|17|Jj7,91)|_J980,956)||
|NETCURRENTASSETS||848,686||1.031.060|
|TOTAL ASSETS LESS CURRENT LIABILITIES||12,775,242||13,480.340|
|CREDITORS<br>Amounts falling due after more than one year|18|(1,339,200)||(1,390,200)|
|NET ASSETS||11,436,042||i290,140|
|FUNDS<br>Unrestricted funds|20|11436,042||12090,140|
|TOTAL FUNDS||11,436,042||12,090,140|





## 

## 

|||2021|2020|
|---|---|---|---|
||Notes|£|£|
|Cash flow from operating activities||||
|Net cash (used inprovided by operating activities|a|(61,883)|(597241)|
|Cash flows from investing activities||||
|Purchase of intangible assets||-|(7,936)|
|Purchase of property, plant and equipment||(468)|(220692)|
|Interest received|||-|
|Net cash used in investing activities||(468)|(228628)|
|Cash flows from financing activities||||
|Loan drawn down||-|600.000|
|Net cash from investing activities||-|600,000|
|Change in cash and cash equivalents in the reporting period||(62,352)|(225,869)|
|Cash and cash equivalents at the beginning of the reporting||522,172|748,041|
|period||||
|Cash and cash equivalents at the end of the reporting|b|459.820|522,172|
|period||||





## 

## 

## 

|||2021|2020|
|---|---|---|---|
|||£|£|
||Net (expenditure)/income for reporting period (as per the|(654097)|(906722)|
||statement of financial activities)|||
||Amortisation of intangible assets|10,605|17,428|
||Depreciation charges|512586|530,537|
||Interest received|-||
||(lncrease)/decrease in stocks|72770|(29,080)|
||Decrease/Oncrease) in debtors|(526,100)|27.369|
||(Increase) in prepayments|(3.6C3)|-|
||(Decrease)/increase in creditors|426.956|(236,773)|
||Sales of lease of Bungalow|99,000|-|
||Net cash provided by operating activities|(61,883)|(597.241)|
|b.|ANALYSIS OF CASH AND CASH EQUIVALENTS|||
|||2021|2020|
|||£|£|
||Cash|459,820|522,172|



## 

|ANALYSIS OF CHANGES IN NET DEBT||||
|---|---|---|---|
||At||At31|
||1 January|Cash flow|December|
||2021||2021|
||£|£|£|
|Net cash:||||
|Cash at bank|522,172|62,352|459,820|
|Bank Loan due in greater than one year|||-|
||522,172|62,352|459,820|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|3.|DONATIONS AND LEGACIES|||
|---|---|---|---|
|||2021|2020|
|||£|£|
||Legacies and Donations|3,483|-|
|4.|INVESTMENT INCOME|||
|||2021|2020|
|||£|£|
||Bank interest|||





## 

## 

|INCOMI|NG RES|OURCES FROM CHARIT|ABLE ACTIVITIES||
|---|---|---|---|---|
||||2021|2020|
||||£|£|
|Medical|services|provided|13,448,758|9,826,734|



||Direct Medical|Support costs|Governance|Total|Total|
|---|---|---|---|---|---|
||costs|(see note 12)|Costs (see|2021|2020|
||(see note 7)||note 8)|||
||£|£|£|£|£|
|Medical services|11,220,780|2976,392|27,122|14,224,294|10,797,843|
|Provided||||||



||2021|2020|
|---|---|---|
||£|£|
|Staff costs|3,225,011|2,871,466|
|Direct medical costs|6,974,699|4,051,503|
|Insurance|576,609|333,167|
|Patient services|119,098|111,108|
|Medical Equipment Maintenance and Repair|325,364|278,146|
||11,220,780|7,645,390|



||2021|2020|
|---|---|---|
||£|£|
|Auditors’ remuneration|27.122|20.880|
|NET (EXPENDITURE)/INCOME|||
|Net (expendsture)/income is stated after charging/(crediting):|||
||2021|2020|
||£|£|
|Amortisation of intangible assets|10.605|17.428|
|Depreciation of owied assets|512586|530.537|



## 



## 

## 

## 

## 

|||2021||2020|
|---|---|---|---|---|
|||£||£|
|Salaries and wages:|||||
|-|Nursing and other clinical staff|2,564,163||2,509237|
|—|Housekeeping, catering and maintenance|496,264||509,638|
|—|Management and administration|1,223,899|-|1,163.997|
|||4,284.326||4,182,872|
|Wage|and salaries|3,868,175||3,781,420|
|Social|security costs|316,232||305,739|
|Pension costs||99,919||95,713|
|||4,284,326||4,182,872|



|The following number of employees received remuneration falling within the|The following number of employees received remuneration falling within the|following ranges:|
|---|---|---|
||2021|2020|
||Number|Number|
|£100,001 -110,000|1|1|



||2021|2020|
|---|---|---|
|Nursing and other clinical|102|112|
|Management, clerical and domestic|97|95|
||199|207|



## 

||2021|2020|
|---|---|---|
||£|£|
|Management|1,590,405|1,813,105|
|Finance|103,307|70,490|
|Information Technology|363,688|305,652|
|Property|918,992|942,327|
||2,976,392|3,131,573|






## 

## 

## 

|INTANGIBLE FIXED ASSETS||
|---|---|
||Total|
||Software|
||£|
|COST||
|Ati January2021|118,503|
|Additions||
|At 31 December 2021|118,503|
|DEPRECIATION||
|At 1 January 2021|92,427|
|Charge for year|10,605|
|At 31 December 2021|103,032|
|NET BOOK VALUE||
|At 31 December 2021|15,471|
|At 31 December 2020|26,076|



## 

|||||Medical||
|---|---|---|---|---|---|
|||||Equipment,||
|||Freehold<br>land|Freehold<br>property|Fixtures,<br>Fittings,|Total|
|||||Computer||
|||||Equipment||
|||£|£|£|£|
|COST||||||
|At|1 January 2021|3,366,366|8,806,318|3,297,786|15,470,470|
|Additions||||468|468|
|At|31 December 2021|3,366,366|8,806,318|3,298,254|15,470,938|
|DEPRECIATION||||||
|At|1 January 2021|-|1,189,012|1,858,254|3,047,266|
|Charge for year||-|178,440|334,146|512,586|
|At|31 December 2021|-|1,367,452|2,192,400|3,559,852|
|NET BOOK VALUE||||||
|At|31 December2021|3.366.366|L4I|L1QL4|11.911.086|
|At|31 December2020|3.366,3|7.617,306|.1,439.532|12.423,204|



## 

|STOCKS|||||
|---|---|---|---|---|
||||2021|2020|
||||£|£|
|Consumable|medical|supplies|254,543|326,910|
|Pharmacy|||25,876|26,278|
||||280,419|353,188|





## 

## 

## 

||2021|2020|
|---|---|---|
||£|£|
|Trade debtors|1419625|872562|
|Prepayments and accrued income|346734|364.094|
||1766359|1.236.656|



## 

||2021|2020|
|---|---|---|
||£|£|
|Trade creditors|803,841|498,915|
|Social security and other taxes|97,810|95,807|
|Accruals and deferred income|606,261|486,234|
|CBILS Loan (Note 19)|150,000||
||1,657,912|1,080,956|



## 

|||2021|2020|
|---|---|---|---|
|||£|£|
|CBILS|Loan (Note 19)|450,000|600,000|
|Lease|deposits|889,200|790,200|
|||1,339,200|1,390,200|



## 



## 

## 

## 

|OVEMENT IN|FUNDS|||||||
|---|---|---|---|---|---|---|---|
||At|Incoming|Resources|Funds|Gains||At|
||January|Resources|Expended|transferred|and||December|
||2021||||Losses||2021|
||£|£|£|£|£||£|
|Unrestricted||||||||
|funds||||||||
|General fund|12,090,140|13,570,196|14,224,294|-||-|11,436,042|
|Total Funds|12,090,140|13,570.196|14,224,294|-||-|11,436,042|



## 

|21.|ANALYSIS OF RESERVES|||
|---|---|---|---|
|||2021|2020|
|||£|£|
||Total reserves|11,436,042|12,090,140|
||Less: Land and buildings|(10,228,158)|(10.406.598)|
||Add: Lease deposits relating to land and buildings|889200|790,200|
||Freely available reserves|2,097,084|2,473,742|
|22.|FINANCIAL INSTRUMENTS|||
|||2021|2020|
|||£|£|
||Financial assets measured at amortised cost|1,879.444|1,428,476|
||Financial liabilities measured at amortised cost|2.293,041|1889,115|



## 

